The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
By E. von Elm, Douglas G. Altman, Matthias Egger, Stuart J. Pocock, P. Gøtzsche, Jan P. Vandenbroucke. Preventive Medicine, 2007
9,582 citations recorded by the source corpus.
Subfields: Sociology and Political Science, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/1b33b74fe5eac26cd9e207bc0d5a477e7aa5391b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Sociology and Political Science
- Jan Derks
- C. Tomasi
- Lehana Thabane
- Gillian Lancaster
- Karel G. M. Moons
- Douglas G. Altman
- Gary S. Collins
- David Moher
In Statistics and Probability
- Gary S. Collins
- Karel G. M. Moons
- Johannes B Reitsma
- Douglas G. Altman
- S. Taube
- Lisa M. McShane
- Zhenshun Cheng
- Xiaofeng Wang
Citations in the corpus
- Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures (2014, neutral): “This is exemplified by its use in a growing number of published guidelines including: CONSORT (CONsoli-dated Standards Of Reporting Trials) [3], STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) [4], TREND (Transparent Reporting of Evaluations with Nonrandomized Designs) ”
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012, methodology): “It is analogous to the CONSORT [8] and STROBE [176] flow diagrams, but gives the information in a more condensed way and may make a flow diagram, as shown in the examples, redundant (see also Item 2).”
- Guidelines for reporting non-randomised pilot and feasibility studies (2019, methodology): “The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guideline [30] provides a checklist of items that should be included in these types of reports, and most items are applicable to pilot and feasibility studies.”
- Peri-implant health and disease. A systematic review of current epidemiology. (2015, methodology): “In order to assess the quality of reporting the STROBE checklist (Vandenbroucke et al. 2007; von Elm et al. 2008) was applied.”
- Cross-Sectional Studies: Strengths, Weaknesses, and Recommendations. (2020, methodology): “We suggest that investigators report their cross-sectional studies following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement, which contains a checklist of 22 items that are considered essential to report.(22) In the STROBE initiative’s explanation and ela”